$1.96
+0.06 (+3.16%)
Open$1.91
Previous Close$1.90
Day High$2.04
Day Low$1.82
52W High$19.35
52W Low$1.70
Volume—
Avg Volume52.9K
Market Cap18.96M
P/E Ratio—
EPS$-4.34
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+329.6% upside
Current
$1.96
$1.96
Target
$8.42
$8.42
$5.85
$8.42 avg
$9.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.66M | 19.11M | 19.03M |
| Net Income | -1,423,753 | -1,667,488 | -1,447,772 |
| Profit Margin | -6.6% | -8.7% | -7.6% |
| EBITDA | -1,912,051 | -1,729,452 | -1,852,839 |
| Free Cash Flow | -992,506 | -967,985 | -917,697 |
| Rev Growth | +8.7% | -4.8% | +0.2% |
| Debt/Equity | 0.16 | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |